Overview

Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fasting Condition

Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
This is an single dose,two-way, crossover, oral bioequivalence study.
Phase:
Phase 1
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited
Treatments:
Anticonvulsants
Lamotrigine